Document Detail

Long-term effects of Graves' ophthalmopathy on health-related quality of life.
MedLine Citation:
PMID:  12039694     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Little is known about the long-term effects of Graves' ophthalmopathy (GO) on health-related quality of life (HRQL) after the eye treatment is considered to be finished. The aim of this study was to quantify these effects using validated HRQL questionnaires. DESIGN: A cross-sectional follow-up study was carried out in GO patients who had started radiotherapy and/or prednisone treatment between 1982 and 1992. METHODS: Between 1998 and 2000 these patients received an HRQL questionnaire containing the SF-36, EuroQol and GO-QOL questionnaires. All patients were invited for a follow-up ophthalmological examination. HRQL scores of the respondents were compared with those of two reference populations of 'healthy' persons and to scores of several other GO populations. RESULTS: One hundred and sixty-eight patients were included; 163 completed the HRQL questionnaire and 154 visited the outpatient clinic. The median follow-up was 11.7 years. A considerable number of symptoms related to GO were found. More than half of the patients had diplopia and 28% had a low visual acuity. Sixty per cent had a proptosis of at least 20 mm. The HRQL scores were considerably better than those of newly diagnosed GO patients (untreated) and GO patients who completed the questionnaire during treatment, but worse than those of 'healthy' persons. Although we did not perform a longitudinal study, we included a selected group of patients who had been treated with radiotherapy and/or prednisone in the Academic Medical Centre of the University of Amsterdam, and though we could not assess HRQL at comparable times after receiving treatment, this is the first study that presents any data on the long-term effects of GO on HRQL. CONCLUSION: GO has a marked negative effect on HRQL, even many years after treatment. These findings suggest that GO should be considered a chronic disease. Aftercare is needed for these patients after their immunosuppressive and surgical treatments.
Caroline Terwee; Iris Wakelkamp; Stevie Tan; Friedo Dekker; Mark F Prummel; Wilmar Wiersinga
Related Documents :
17142014 - Validity of the eq-5d in assessing and valuing health status in patients with schizophr...
14635284 - Evaluation of health-related quality of life of rheumatoid arthritis patients treated w...
11351374 - Psychosocial interventions for cancer: review and analysis using a three-tiered outcome...
15707134 - Safety and efficacy of extracorporeal shock wave therapy for chronic lateral epicondyli...
1868824 - The development of a seizure severity scale as an outcome measure in epilepsy.
22542434 - A short version of the international hip outcome tool (ihot-12) for use in routine clin...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of endocrinology / European Federation of Endocrine Societies     Volume:  146     ISSN:  0804-4643     ISO Abbreviation:  Eur. J. Endocrinol.     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-05-31     Completed Date:  2002-07-24     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  9423848     Medline TA:  Eur J Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  751-7     Citation Subset:  IM    
Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cross-Sectional Studies
Follow-Up Studies
Graves Disease / psychology*
Health Status*
Middle Aged
Quality of Life*
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chr...
Next Document:  Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfun...